Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | (-)-demecolcine | increases expression | ISO | ANKRD28 (Homo sapiens) | 6480464 | Demecolcine results in increased expression of ANKRD28 mRNA | CTD | PMID:23649840 | 1,2-dimethylhydrazine | decreases expression | ISO | Ankrd28 (Mus musculus) | 6480464 | 1 and 2-Dimethylhydrazine results in decreased expression of ANKRD28 mRNA | CTD | PMID:22206623 | 17beta-estradiol | decreases expression | EXP | | 6480464 | Estradiol results in decreased expression of ANKRD28 mRNA | CTD | PMID:32145629 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of ANKRD28 mRNA | CTD | PMID:21215274 | 3,3',4,4'-tetrachlorobiphenyl | multiple interactions | ISO | Ankrd28 (Mus musculus) | 6480464 | 3 more ... | CTD | PMID:19467301 | 4-hydroxyphenyl retinamide | increases expression | ISO | Ankrd28 (Mus musculus) | 6480464 | Fenretinide results in increased expression of ANKRD28 mRNA | CTD | PMID:28973697 | acrylamide | decreases expression | ISO | ANKRD28 (Homo sapiens) | 6480464 | Acrylamide results in decreased expression of ANKRD28 mRNA | CTD | PMID:32763439 | aflatoxin B1 | decreases methylation | ISO | ANKRD28 (Homo sapiens) | 6480464 | Aflatoxin B1 results in decreased methylation of ANKRD28 gene | CTD | PMID:27153756 | all-trans-retinoic acid | decreases expression | ISO | ANKRD28 (Homo sapiens) | 6480464 | Tretinoin results in decreased expression of ANKRD28 mRNA | CTD | PMID:23724009 | arsenite(3-) | multiple interactions | ISO | ANKRD28 (Homo sapiens) | 6480464 | arsenite inhibits the reaction [G3BP1 protein binds to ANKRD28 mRNA] | CTD | PMID:32406909 | benzo[a]pyrene | decreases expression | ISO | ANKRD28 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in decreased expression of ANKRD28 mRNA | CTD | PMID:20064835 and PMID:20106945 | benzo[a]pyrene | decreases methylation | ISO | ANKRD28 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in decreased methylation of ANKRD28 promoter | CTD | PMID:27901495 | benzo[a]pyrene | increases methylation | ISO | Ankrd28 (Mus musculus) | 6480464 | Benzo(a)pyrene results in increased methylation of ANKRD28 intron | CTD | PMID:27901495 | benzo[a]pyrene | decreases expression | ISO | Ankrd28 (Mus musculus) | 6480464 | Benzo(a)pyrene results in decreased expression of ANKRD28 mRNA | CTD | PMID:19770486 | benzo[a]pyrene diol epoxide I | decreases expression | ISO | ANKRD28 (Homo sapiens) | 6480464 | 7 more ... | CTD | PMID:19150397 | bisphenol A | decreases expression | ISO | ANKRD28 (Homo sapiens) | 6480464 | bisphenol A results in decreased expression of ANKRD28 mRNA | CTD | PMID:22576693 | bisphenol A | increases expression | ISO | ANKRD28 (Homo sapiens) | 6480464 | bisphenol A results in increased expression of ANKRD28 mRNA | CTD | PMID:36232920 | bisphenol A | increases expression | ISO | Ankrd28 (Mus musculus) | 6480464 | bisphenol A results in increased expression of ANKRD28 mRNA | CTD | PMID:37894381 | bisphenol A | multiple interactions | ISO | ANKRD28 (Homo sapiens) | 6480464 | [[ginger extract results in increased abundance of Oils more ... | CTD | PMID:31601247 and PMID:33376534 | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of ANKRD28 mRNA | CTD | PMID:32145629 | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of ANKRD28 mRNA | CTD | PMID:25181051 and PMID:30816183 | bisphenol A | increases methylation | ISO | ANKRD28 (Homo sapiens) | 6480464 | bisphenol A results in increased methylation of ANKRD28 gene | CTD | PMID:22576693 and PMID:31601247 | cadmium dichloride | decreases expression | EXP | | 6480464 | Cadmium Chloride results in decreased expression of ANKRD28 mRNA | CTD | PMID:33453195 | carbamazepine | affects expression | ISO | ANKRD28 (Homo sapiens) | 6480464 | Carbamazepine affects the expression of ANKRD28 mRNA | CTD | PMID:25979313 | carbon nanotube | increases expression | ISO | Ankrd28 (Mus musculus) | 6480464 | Nanotubes more ... | CTD | PMID:25554681 and PMID:25620056 | chlorpyrifos | decreases expression | ISO | Ankrd28 (Mus musculus) | 6480464 | Chlorpyrifos results in decreased expression of ANKRD28 mRNA | CTD | PMID:37019170 | clofibrate | multiple interactions | ISO | Ankrd28 (Mus musculus) | 6480464 | [Clofibrate co-treated with Acetaminophen] affects the expression of ANKRD28 mRNA and PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of ANKRD28 mRNA] | CTD | PMID:17585979 | cyclosporin A | increases expression | ISO | ANKRD28 (Homo sapiens) | 6480464 | Cyclosporine results in increased expression of ANKRD28 mRNA | CTD | PMID:20106945 | dibutyl phthalate | increases expression | EXP | | 6480464 | Dibutyl Phthalate results in increased expression of ANKRD28 mRNA | CTD | PMID:21266533 | dioxygen | multiple interactions | ISO | Ankrd28 (Mus musculus) | 6480464 | [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ANKRD28 mRNA | CTD | PMID:30529165 | dorsomorphin | multiple interactions | ISO | ANKRD28 (Homo sapiens) | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ANKRD28 mRNA | CTD | PMID:27188386 | doxorubicin | decreases expression | ISO | ANKRD28 (Homo sapiens) | 6480464 | Doxorubicin results in decreased expression of ANKRD28 mRNA | CTD | PMID:29803840 | entinostat | multiple interactions | ISO | ANKRD28 (Homo sapiens) | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ANKRD28 mRNA | CTD | PMID:27188386 | entinostat | decreases expression | ISO | ANKRD28 (Homo sapiens) | 6480464 | entinostat results in decreased expression of ANKRD28 mRNA | CTD | PMID:26272509 | ethanol | decreases expression | ISO | Ankrd28 (Mus musculus) | 6480464 | Ethanol results in decreased expression of ANKRD28 mRNA | CTD | PMID:29018328 | etoposide | affects response to substance | ISO | ANKRD28 (Homo sapiens) | 6480464 | ANKRD28 protein affects the susceptibility to Etoposide | CTD | PMID:16217747 | fenthion | decreases expression | ISO | Ankrd28 (Mus musculus) | 6480464 | Fenthion results in decreased expression of ANKRD28 mRNA | CTD | PMID:34813904 | finasteride | increases expression | EXP | | 6480464 | Finasteride results in increased expression of ANKRD28 mRNA | CTD | PMID:24136188 | flutamide | decreases expression | EXP | | 6480464 | Flutamide results in decreased expression of ANKRD28 mRNA | CTD | PMID:24136188 | folic acid | decreases expression | ISO | Ankrd28 (Mus musculus) | 6480464 | Folic Acid results in decreased expression of ANKRD28 mRNA | CTD | PMID:25629700 | formaldehyde | increases expression | ISO | ANKRD28 (Homo sapiens) | 6480464 | Formaldehyde results in increased expression of ANKRD28 mRNA | CTD | PMID:23649840 | fulvestrant | multiple interactions | ISO | ANKRD28 (Homo sapiens) | 6480464 | [bisphenol A co-treated with Fulvestrant] results in increased methylation of ANKRD28 gene | CTD | PMID:31601247 | gentamycin | increases expression | EXP | | 6480464 | Gentamicins results in increased expression of ANKRD28 mRNA | CTD | PMID:22061828 | glyphosate | affects methylation | EXP | | 6480464 | Glyphosate affects the methylation of ANKRD28 gene | CTD | PMID:35440735 | irinotecan | decreases expression | ISO | ANKRD28 (Homo sapiens) | 6480464 | Irinotecan analog results in decreased expression of ANKRD28 mRNA | CTD | PMID:18927307 | ivermectin | decreases expression | ISO | ANKRD28 (Homo sapiens) | 6480464 | Ivermectin results in decreased expression of ANKRD28 protein | CTD | PMID:32959892 | manganese(II) chloride | increases expression | EXP | | 6480464 | manganese chloride results in increased expression of ANKRD28 mRNA | CTD | PMID:28801915 | melphalan | decreases expression | ISO | ANKRD28 (Homo sapiens) | 6480464 | Melphalan results in decreased expression of ANKRD28 mRNA | CTD | PMID:22363485 | methidathion | decreases expression | ISO | Ankrd28 (Mus musculus) | 6480464 | methidathion results in decreased expression of ANKRD28 mRNA | CTD | PMID:34813904 | methylmercury chloride | increases expression | ISO | ANKRD28 (Homo sapiens) | 6480464 | methylmercuric chloride results in increased expression of ANKRD28 mRNA | CTD | PMID:23179753 and PMID:27188386 | methylmercury chloride | decreases expression | ISO | ANKRD28 (Homo sapiens) | 6480464 | methylmercuric chloride results in decreased expression of ANKRD28 mRNA | CTD | PMID:28001369 | N-methyl-4-phenylpyridinium | increases expression | ISO | Ankrd28 (Mus musculus) | 6480464 | 1-Methyl-4-phenylpyridinium results in increased expression of ANKRD28 mRNA | CTD | PMID:17475336 | N-methyl-4-phenylpyridinium | increases expression | EXP | | 6480464 | 1-Methyl-4-phenylpyridinium results in increased expression of ANKRD28 mRNA | CTD | PMID:28801915 | p-toluidine | decreases expression | EXP | | 6480464 | 4-toluidine results in decreased expression of ANKRD28 mRNA | CTD | PMID:27638505 | paracetamol | multiple interactions | ISO | Ankrd28 (Mus musculus) | 6480464 | [Clofibrate co-treated with Acetaminophen] affects the expression of ANKRD28 mRNA and PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of ANKRD28 mRNA] | CTD | PMID:17585979 | paracetamol | affects response to substance | ISO | ANKRD28 (Homo sapiens) | 6480464 | ANKRD28 gene polymorphism affects the susceptibility to Acetaminophen | CTD | PMID:26104854 | paracetamol | decreases expression | ISO | ANKRD28 (Homo sapiens) | 6480464 | Acetaminophen results in decreased expression of ANKRD28 mRNA | CTD | PMID:21420995 | raloxifene | multiple interactions | ISO | ANKRD28 (Homo sapiens) | 6480464 | [Raloxifene Hydrochloride co-treated with ESR1 protein] results in decreased expression of ANKRD28 mRNA | CTD | PMID:19059307 | SB 431542 | multiple interactions | ISO | ANKRD28 (Homo sapiens) | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ANKRD28 mRNA | CTD | PMID:27188386 | sulindac | decreases expression | EXP | | 6480464 | Sulindac results in decreased expression of ANKRD28 mRNA | CTD | PMID:24136188 | tamoxifen | multiple interactions | ISO | ANKRD28 (Homo sapiens) | 6480464 | [Tamoxifen co-treated with ESR1 protein] results in decreased expression of ANKRD28 mRNA | CTD | PMID:19059307 | tetrachloromethane | decreases expression | ISO | Ankrd28 (Mus musculus) | 6480464 | Carbon Tetrachloride results in decreased expression of ANKRD28 mRNA | CTD | PMID:17484886 | thioacetamide | increases expression | EXP | | 6480464 | Thioacetamide results in increased expression of ANKRD28 mRNA | CTD | PMID:34492290 | trichostatin A | increases expression | ISO | ANKRD28 (Homo sapiens) | 6480464 | trichostatin A results in increased expression of ANKRD28 mRNA | CTD | PMID:24935251 and PMID:26705709 | tungsten | decreases expression | ISO | Ankrd28 (Mus musculus) | 6480464 | Tungsten results in decreased expression of ANKRD28 mRNA | CTD | PMID:30912803 | ursodeoxycholic acid | affects expression | ISO | ANKRD28 (Homo sapiens) | 6480464 | Ursodeoxycholic Acid affects the expression of ANKRD28 mRNA | CTD | PMID:18422935 | valproic acid | decreases expression | ISO | ANKRD28 (Homo sapiens) | 6480464 | Valproic Acid results in decreased expression of ANKRD28 mRNA | CTD | PMID:23179753 and PMID:28001369 | valproic acid | affects splicing | EXP | | 6480464 | Valproic Acid affects the splicing of ANKRD28 mRNA | CTD | PMID:29427782 | |